Search
for
Sort by
Research 91–120 of 1000+
- Deficiency in alopecia areata and responsiveness to vitamin D analogues: A prospective trial
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
- Dermal lymphatic dilation in a mouse model of alopecia areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Hair loss after covid 19 - case series
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- RETRACTED: Causal role of immune cells in alopecia areata: A two‐sample Mendelian randomization study
- Platelet-Rich Plasma in Alopecia Areata—A Steroid-Free Treatment Modality: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- A new self‐reported measure of disease severity of scalp hair loss in alopecia areata
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Association Between Alopecia Areata and High‐Sensitivity Cardiac Troponin T as a Marker of Subclinical Myocardial Injury
- Alopecia Areata and Toxic Metals
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Alopecia Areata: An Updated Review for 2023
- Alopecia areata: current concepts
- Illness Perception, Emotional Distress, and Obsessive–Compulsive Symptomatology in Patients with Alopecia Areata: A Mediation Study
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Low-level light therapy (LLLT) for cosmetics and dermatology
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Prevalence of Clinical Manifestations Known to Be Associated With Insulin Resistance Among Female Medical Students of a Private College in Saudi Arabia
- Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Efficacy and safety of treatments in alopecias
- Hair-Raising News
- Association between non-scarring alopecia and hypothyroidism: a bidirectional two-sample Mendelian randomization study